CE Credit | Hepatitis C Online | 5 | Treatment of HCV Genotype 2

This course discusses the preferred therapies for initial treatment and retreatment (of prior relapsers) of patients who have genotype 2 chronic HCV. Also discussed is the preferred therapy for retreatment of patients with HCV genotype 2 chronic infection who have failed therapy with a prior nonresponse (partial response or null response).

Target Audience

Primary care physicians, advanced registered nurse practitioners, physician assistants, hospitalizes, infectious disease specialists, gastroenterologists and hepatologists

Objectives for Learning Outcomes

After completing this course, you will be better able to:

  • Discuss preferred therapies for initial treatment and retreatment (of prior relapsers) who have genotype 2 chronic HCV.
  • List the preferred therapy for retreatment of patients with HCV genotype 2 chronic infection who have failed therapy with a prior nonresponse (partial response or null response).

Additional Information

Format: 
CE Certificate Only
Topics: 

Initial Treatment and Retreatment with Prior Relapse
Retreatment of Prior Nonresponders
EASL 2014 HCV Treatment Recommendations

Course summary
Maximum credit available: 
  • 1.00 Contact hours
Available: 
05/06/2014
Expires: 
05/06/2017

David H. Spach, MD
Professor of Medicine, Division of Infectious Diseases, University of Washington

 

Available Credit

  • 1.00 Contact hours
Please login or create account to take this course.